AZO
43
-2
GM
82
2
DO
83
2
UPS
55
4
DFS
62
-5
HPE
48
-2
GIS
61
4
MSFT
62
-2
KO
62
2
TXN
53
-2
DVA
72
-3
CHK
20
-19
FCX
54
-16
SLG
64
-2
MU
60
-2
HSY
66
2
ADP
66
2
FSLR
75
2
USB
39
-5
CVS
41
2
AZO
43
-2
GM
82
2
DO
83
2
UPS
55
4
DFS
62
-5
HPE
48
-2
GIS
61
4
MSFT
62
-2
KO
62
2
TXN
53
-2
DVA
72
-3
CHK
20
-19
FCX
54
-16
SLG
64
-2
MU
60
-2
HSY
66
2
ADP
66
2
FSLR
75
2
USB
39
-5
CVS
41
2
Financhill
Back

Corcept Therapeutics Stock Predictions

Buy
80

CORT
Corcept Therapeutics

Last Price:
28.09
Seasonality Move:
8.36%

7 Day Trial

ALL ACCESS PASS

$ 7

Corcept Therapeutics Stock Forecast

  • Over the next 52 weeks, Corcept Therapeutics has on average historically risen by 33.1% based on the past 20 years of stock performance.
  • Corcept Therapeutics has risen higher in 11 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 55%
  • Is Corcept Therapeutics Stock Undervalued?
    The current Corcept Therapeutics [CORT] share price is $28.09. The Score for CORT is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • CORT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Corcept Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Corcept Therapeutics has on average historically risen by 33.1% based on the past 20 years of stock performance.

Corcept Therapeutics Stock Rating

Buy
80
Corcept Therapeutics (CORT) is a Buy

Is Corcept Therapeutics overpriced?

  • Corcept Therapeutics has risen higher in 11 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 55%

Corcept Therapeutics Stock Price History

Is CORT stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
corcept.com

52-Week Data

52-Week High:
34.28
52-Week Low:
20.84

Prediction Charts

Market Cap:
2.92B
Price in USD:
28.09
Volume:
823.35K
Beta:
0.83

Technical Analysis

SMA50:
24.55
SMA100:
24.34
SMA200:
26.69
52-Wk Change:
14.93%

Stock Predictions

  • Is Corcept Therapeutics stock public?
    Yes, Corcept Therapeutics is a publicly traded company.
  • What is the Corcept Therapeutics stock quote today?
    The Corcept Therapeutics stock price is 28.09 USD today.
  • How to buy Corcept Therapeutics stock online?
    You can buy Corcept Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-30 23.47 23.33 23.94 23.29
May-1 23.09 23.88 24.61 22.60
May-2 26.39 25.08 26.39 23.80
May-3 25.06 24.52 25.22 23.11
May-6 24.52 23.97 24.58 23.02
May-7 24.17 24.48 24.62 23.61
May-8 24.26 25.40 25.54 23.90
May-9 25.49 26.62 26.62 25.35
May-10 26.83 27.04 27.48 26.53
May-13 27.35 27.53 29.27 27.23
May-14 27.87 27.66 28.18 26.87
May-15 28.12 27.83 28.46 27.63
May-16 27.67 27.54 27.93 27.35
May-17 27.57 28.09 28.33 27.53

Corcept Therapeutics Earnings

Corcept Therapeutics Earnings Report: Per Share Corcept Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Corcept Therapeutics Forecast Revenue Growth

Corcept Therapeutics Stock Analysis: Historical quarterly revenues per share for Corcept Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.02 per share, an increase this year of $0.08 per share, and an increase next year of $0.05 per share.

* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.